Prot #M23‑477: A Phase 1 First‑In‑Human Study Evaluating Safety, Pharmacokinetics, and Efficacy of ABBV‑787 in Adult Subjects with Acute Myeloid Leukemia (AML)

Project: Research project

Project Details

StatusActive
Effective start/end date12/7/23 → 12/7/27

Funding

  • Parexel (Prot # M23-477 // Prot # M23-477)
  • AbbVie Inc. (Prot # M23-477 // Prot # M23-477)